First Time Loading...

Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.42 USD 2.16% Market Closed
Updated: May 1, 2024
Section:
 

Relative Value

IDXG doesn't have a meaningful market cap.

The Relative Value of one IDXG stock under the Base Case scenario is 5.52 USD. Compared to the current market price of 1.42 USD, Interpace Biosciences Inc is Undervalued by 74%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IDXG Relative Value
Base Case
5.52 USD
Undervaluation 74%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.2
P/S
P/S
Price to Sales
0.2
vs History
75
vs Industry
90
Median 3Y
0.3
Median 5Y
0.6
Industry
2.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-1.1
Industry
23.2
More Details
2.6
P/OCF
P/OCF
Price to OCF
2.6
vs History
0
vs Industry
51
Median 3Y
-2.1
Median 5Y
-1.6
Industry
15.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
40
Median 3Y
-1.4
Median 5Y
-1.5
Industry
23.5
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
Median 3Y
-0.3
Median 5Y
0.6
Industry
2.2
More Details
0.3
EV/S
EV/S
Enterprise Value to Sales
0.3
vs History
69
vs Industry
84
Median 3Y
0.5
Median 5Y
0.6
Industry
2.5
More Details
0.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.6
vs History
82
vs Industry
84
Median 3Y
0.9
Median 5Y
1.1
Industry
5.2
More Details
4.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
4.4
vs History
14
vs Industry
48
Median 3Y
-2.3
Median 5Y
-1.6
Industry
12.5
More Details
7.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
7.9
vs History
4
vs Industry
42
Median 3Y
-2.8
Median 5Y
-1.6
Industry
17.2
More Details
5.3
EV/OCF
EV/OCF
Enterprise Value to OCF
5.3
vs History
0
vs Industry
47
Median 3Y
-2.8
Median 5Y
-2
Industry
15.1
More Details
6.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
6.8
vs History
0
vs Industry
38
Median 3Y
-2.7
Median 5Y
-2
Industry
19.7
More Details
1.6
EV/IC
EV/IC
Enterprise Value to IC
1.6
vs History
6
vs Industry
45
Median 3Y
1.3
Median 5Y
0.9
Industry
2
More Details

Multiples Across Competitors

IDXG Competitors Multiples
Interpace Biosciences Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Interpace Biosciences Inc
OTC:IDXG
6.1m USD 0.2 -3.8 4.4 7.9
US
Cigna Corp
NYSE:CI
104.4B USD 0.5 20.2 10.4 13.8
US
Cigna Group
XMUN:CGN
96.9B EUR 0.5 20 10.3 13.7
US
CVS Health Corp
NYSE:CVS
72.9B USD 0.2 8.7 8 8
DE
Fresenius Medical Care AG
XMUN:FME
22.7B EUR 1.2 45.6 10.6 25.1
US
Laboratory Corporation of America Holdings
NYSE:LH
16.9B USD 1.4 39 11.9 17.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.8B EUR 0.7 -26.5 10.1 22.6
US
Quest Diagnostics Inc
NYSE:DGX
15.2B USD 1.6 18.1 10.7 14.5
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.6B EUR 0.6 23.3 6.9 16.4
US
DaVita Inc
NYSE:DVA
12.3B USD 1 17.7 8.6 12.6
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
IDXG intrinsic value, competitors valuation, and company profile.
DCF Valuation
IDXG stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IDXG stock valuation using valuation multiples.
Wall Street Estimates
IDXG price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IDXG stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.